Can peripheral infections affect the brain without proving cognitive decline is caused by infection?

Peripheral infection can plausibly contribute to acute brain dysfunction—particularly in older adults—but a positive pathogen-specific antibody result is not, by itself, evidence that an infection is active in the CNS or responsible for cognitive decline.

Clinical and diagnostic evidence

• Peripheral infections reliably increase circulating inflammatory mediators, notably IL-1β, IL-6, and TNF-α. In older adults with acute bacterial infection, higher IL-6, TNF-α, and IL-1β have been associated with delirium or pre-existing cognitive dysfunction; an acute-hospital cohort found delirium associated with elevated IL-6 and IL-8 even after adjustment for infection, age, and baseline cognitive impairment.
• These associations support inflammatory contributions to delirium and other acute brain dysfunction, but cytokines are nonspecific and cannot independently establish the cause of an individual’s cognitive symptoms.
• Serum pathogen-specific IgM or IgG may indicate remote exposure, vaccination, cross-reactivity, or false positivity. Persistence can be prolonged: in Lyme disease, even an elevated CSF:serum antibody index may remain elevated after successful treatment.

Mechanistic basis

• Peripheral immune signals reach or influence the brain through vagal/neural and humoral pathways, signaling at circumventricular organs, and cerebral endothelial activation.
• Cytokine-related blood–brain barrier dysfunction may permit cytokines, chemokines, and immune cells to enter the CNS. Subsequent activation of perivascular macrophages, astrocytes, and microglia can generate neuroinflammation without direct CNS infection.
• Aging, dementia, reduced barrier integrity, and microglial priming may increase susceptibility to disproportionate central effects from systemic illness. Generalized EEG slowing in delirium is compatible with network dysfunction but is not specific for infection-driven inflammation.

Clinical implications

• Attributing cognitive decline to infection requires a compatible syndrome plus corroboration: inflammatory CSF, pathogen-targeted CSF PCR or intrathecal antibody production, supportive MRI/EEG, and assessment of competing infectious, autoimmune, toxic-metabolic, vascular, neoplastic, neurodegenerative, and prion causes.

Bottom line

• Peripheral infection can activate biologically credible inflammatory pathways affecting the brain, but isolated pathogen-specific serology demonstrates immune recognition—not active CNS infection or causation of cognitive decline.